These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26831126)

  • 1. Early HIV treatment to forestall drug resistance.
    Wainberg MA
    Lancet Infect Dis; 2016 May; 16(5):512-513. PubMed ID: 26831126
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV Drug Resistance.
    Gottlieb GS; Raugi DN; Smith RA;
    N Engl J Med; 2018 Mar; 378(9):874-5. PubMed ID: 29504389
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV Drug Resistance.
    Inzaule SC; Rinke de Wit TF; Hamers RL
    N Engl J Med; 2018 Mar; 378(9):873-4. PubMed ID: 29504387
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV Drug Resistance.
    Beyrer C; Pozniak A
    N Engl J Med; 2018 Mar; 378(9):875. PubMed ID: 29490186
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Commentary: HIV Is Putting Up Less Resistance.
    Richman DD
    Clin Infect Dis; 2016 May; 62(10):1318-9. PubMed ID: 26962077
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment-Reply.
    Saag MS; Günthard HF; Smith DM
    JAMA; 2018 Nov; 320(20):2154. PubMed ID: 30480722
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimising the accuracy of HIV drug resistance assays.
    Karim SSA
    Lancet HIV; 2018 Nov; 5(11):e608-e609. PubMed ID: 30282604
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV Drug Resistance.
    Bertagnolio S; Jordan MR; Doherty M
    N Engl J Med; 2018 Mar; 378(9):874. PubMed ID: 29504388
    [No Abstract]   [Full Text] [Related]  

  • 9. We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.
    Brenner B; Wainberg MA
    AIDS; 2016 Nov; 30(17):2725-2727. PubMed ID: 27782967
    [No Abstract]   [Full Text] [Related]  

  • 10. The emergence of acquired HIV-1 drug resistance has nearly stopped in Switzerland.
    Harper KN
    AIDS; 2016 Sep; 30(14):N27. PubMed ID: 27333089
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine.
    Lockman S; McIntyre JA
    Lancet; 2007 Nov; 370(9600):1668-70. PubMed ID: 17997152
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tipranavir optimizes the effect of recent antiretroviral substances. Encouraging options in multiple resistance].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():71. PubMed ID: 19024922
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance.
    Günthard HF; Scherrer AU
    J Infect Dis; 2016 Nov; 214(9):1289-1291. PubMed ID: 27869617
    [No Abstract]   [Full Text] [Related]  

  • 14. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment implications of the latent reservoir for HIV-1.
    Peterson S; Reid AP; Kim S; Siliciano RF
    Adv Pharmacol; 2007; 55():411-25. PubMed ID: 17586322
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of archived resistance after intrapartum nevirapine.
    S Afr Med J; 2004 May; 94(5):334-5. PubMed ID: 15211942
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV drug resistance assessment in the Western Pacific region. A systematic review.
    Yu D; Sutherland D; Ghidinelli M; Jordan M
    AIDS Rev; 2011; 13(4):214-26. PubMed ID: 21975357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP-01A helps with quality of life.
    AIDS Patient Care STDS; 2008 Feb; 22(2):160-1. PubMed ID: 18273942
    [No Abstract]   [Full Text] [Related]  

  • 19. Future of nonnucleoside reverse transcriptase inhibitors.
    Sluis-Cremer N
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):637-638. PubMed ID: 29326232
    [No Abstract]   [Full Text] [Related]  

  • 20. The M184V mutation: what it does, how to prevent it, and what to do with it when it's there.
    Gallant JE
    AIDS Read; 2006 Oct; 16(10):556-9. PubMed ID: 17096474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.